News

Dexcom stock surged Thursday after the Food and Drug Administration cleared its newest diabetes device for an extended 15-day ...
Four years ago, my life changed after a heart attack at the age of 33. While a quick coronary angioplasty meant my heart was ...
The longer wear time should improve Dexcom’s margins and help it compete with Abbott, RBC Capital Markets analyst Shagun ...
The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA clearance on April 10 for adults with ...
San Diego-based Dexcom submitted its 15-day G7 CGM to the FDA in October 2024. The company says its 15-day G7 also meets ...
ABT anticipates annual sales of $10 billion for FreeStyle Libre by 2028. A supply-chain snag due to regulatory action may hit DexCom’s product availability, thereby losing in competition ...